SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles

FIN STREET SEC (01476): Chairman Zhu Yanhui is under investigation and subject to retention measures

China Securities Co.,Ltd.: AI advanced packaging drives upgrading of glass substrate materials; equipment takes the lead in the early stage of industrialization.

Alphabet (GOOGL.US)-linked municipal bond demand cools, $3 billion prepaid energy deal delayed in pricing
FIN STREET SEC (01476): Chairman Zhu Yanhui is under investigation and subject to retention measures

China Securities Co.,Ltd.: AI advanced packaging drives upgrading of glass substrate materials; equipment takes the lead in the early stage of industrialization.

Alphabet (GOOGL.US)-linked municipal bond demand cools, $3 billion prepaid energy deal delayed in pricing






